INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo ARLOFT 50
ARLOFT 100

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
S5

PROPRIETARY NAME
(and dosage form):

ARLOFT 50
ARLOFT 100

COMPOSITION:
ARLOFT 50: each tablet contains Sertraline hydrochloride equivalent to
Sertraline 50,0 mg
ARLOFT 100: each tablet contains Sertraline hydrochloride equivalent to Sertraline 100,0 mg

ATC CLASSIFICATION:
N06AB06

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
ARLOFT 50: A40/1.2/0503
ARLOFT 100: A40/1.2/0504

APPLICANT:
ARROW PHARMA SOUTH AFRICA (PTY) LTD

MANUFACTURER:
no data

AVAILABILITY:
no data - please check with company.

DATE OF REGISTRATION:
October 2008

SOURCE:
REGISTRAR OF MEDICINES
12.43 Notification of Registration Oct08 v1.doc        Nov 2008

Date posted: July 2014

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014